How to Get GLP-1 Patients as a Psychiatrist in Pennsylvania

If you’re a psychiatrist watching the GLP-1 revolution unfold—patients asking about Ozempic, colleagues adding weight management to their services, telehealth platforms recruiting prescribers—you’ve probably wondered: Is this a real opportunity, or just another shiny object that’ll drain my time?

Here’s the reality: this is one of the biggest practice growth opportunities in healthcare right now. By 2025, an estimated 6% of Americans (roughly 20 million people) were taking GLP-1 medications, many specifically for weight loss. That’s a 600% increase in obesity-related usage over just six years. And nearly half of psychiatrists surveyed in late 2023 were already prescribing or recommending these medications to their patients.

But here’s what matters more than the hype: psychiatrists are uniquely positioned to do this well—and to scale it without sacrificing your sanity or your existing practice.

This isn’t about becoming a pill mill or abandoning psychiatric care. It’s about recognizing that many of your patients are already struggling with weight (often medication-induced), that millions of people can’t find providers to prescribe GLP-1s, and that you have skills—behavior change expertise, telehealth fluency, patient relationship management—that most weight-loss clinics don’t.

Let’s break down how to actually do this: how to get patients, what the regulations look like, and most importantly, how to scale a GLP-1 practice without burning out.

Why Psychiatrists Are Natural Fits for GLP-1 Care

The Patient Overlap Is Already There

You’re probably already having conversations about weight. Antipsychotics cause weight gain. So do many mood stabilizers. Patients on these medications often feel trapped—choosing between mental stability and physical health.

GLP-1 medications offer a way out of that bind. And because you’re already managing their psychiatric medications, monitoring their mental health, and discussing lifestyle factors, adding weight management isn’t a huge leap—it’s completing the picture.

Beyond medication side effects, there’s significant overlap between psychiatric conditions and obesity. Binge eating disorder, emotional eating tied to depression or anxiety, trauma-related weight gain—these aren’t problems a generic telehealth weight-loss clinic can adequately address. They need someone who understands the psychology, not just the pharmacology.

You Bring What Others Don’t

Most telehealth weight-loss services are transactional: brief video visit, prescription sent, next patient. That model works for some people, but it fails the patients who need more—and those patients are often willing to pay for better care.

You can offer:

• Mental health screening and support (critical given early concerns about mood effects of GLP-1s, even though FDA found no clear suicide risk)
• Behavior change expertise (sustaining weight loss requires addressing the why behind eating patterns)
• Medication management experience (you’re already comfortable with dose titration, side effects, patient education)
• Long-term patient relationships (weight management is chronic care, not a quick fix)

This matters economically too. Patients who feel supported, understood, and monitored are far more likely to stay on treatment long-term. That’s better outcomes and better retention for your practice.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Get GLP-1 Patients (Without Spending a Fortune on Marketing)

Let’s address the elephant in the room: patient acquisition cost.

A lot of marketing consultants will tell you that you can acquire psychiatric patients for $30-50 through SEO or Google Ads. That’s fantasy. The reality for DIY marketing in mental health—and especially for a new service line like GLP-1—looks more like this:

• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per actual booked patient through PPC is $200-400+, often higher when you factor in testing, optimization, and failed campaigns.

• SEO: Takes 6-12 months of consistent investment (content creation, technical optimization, backlinks) before generating meaningful patient flow. Most solo providers don’t have the expertise, budget, or patience.

• Directory listings: Psychology Today, Zocdoc, etc. charge monthly fees ($100-300+) and you’re competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+ per patient), plus subscription fees. Total monthly cost adds up fast.

• True CAC: When you factor in all costs—agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of SEO investment, failed campaigns—acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+.

Now, DIY marketing can eventually become cost-effective IF you have the budget to spend $3,000-5,000/month with uncertain results, the expertise to optimize campaigns yourself, and the patience to wait 6-12 months for SEO to kick in. For most providers—especially those starting out or scaling—that’s gambling, not business strategy.

The Smarter Path: Platform-Based Patient Acquisition

This is where platforms like Klarity Health change the economics entirely.

Instead of spending thousands upfront on marketing with no guarantee of results, Klarity uses a pay-per-appointment model. You pay a standard listing fee per new patient lead that books with you. That’s it. No monthly subscriptions, no wasted ad spend on clicks that don’t convert, no gambling on whether your SEO will work.

Here’s why this matters for a GLP-1 practice:

• Pre-qualified patients: Klarity matches patients to your specialty and availability, so you’re not wasting time on unqualified leads.
• Built-in infrastructure: Telehealth platform, scheduling, patient communication—already handled. No separate platform costs.
• Both insurance and cash-pay flow: Access to patients across payment models.
• You control your schedule: Only see as many patients as you want. Only pay when you actually see them.
• Guaranteed ROI: You know exactly what you’re paying per patient, and you only pay for patients you actually see.

Compare that to spending $4,000/month on Google Ads and SEO with maybe 10-15 new patients if everything goes right, versus paying only when a qualified patient books and shows up.

For most providers, especially those scaling, platforms that handle patient acquisition remove the risk entirely. You’re not gambling—you’re building a predictable pipeline.

Internal Marketing: Start With Who You Already Have

The fastest way to get GLP-1 patients is often internal:

Review your current caseload. How many patients:

• Have gained significant weight on psychiatric medications?
• Have BMI ≥30 (or ≥27 with comorbidities like hypertension, diabetes)?
• Have mentioned wanting to lose weight but feeling stuck?

Bring it up during medication reviews: ‘I’m now offering medical weight management for patients interested in GLP-1 medications like semaglutide. Based on your weight goals and health history, this might be something worth discussing.’

Many patients will say yes immediately. You’ve already established trust, they already see you regularly, and you’re offering a solution to a problem they’ve been living with.

External Marketing That Actually Works

If you want to market externally:

Telehealth platforms (like Klarity) are your highest-volume, lowest-effort option. They handle advertising, lead generation, and patient matching. You focus on clinical care.

Targeted local SEO: Create content addressing your specific market—’GLP-1 Weight Loss for Psychiatric Patients in [Your City]’ or ‘Managing Weight Gain from Antipsychotics.’ This attracts patients searching for solutions to problems they’re actively experiencing.

Referral relationships: Let local PCPs, endocrinologists, therapists, and dietitians know you offer this service. Many are overwhelmed with patient requests for GLP-1s and will gladly refer. A simple email or 5-minute coffee meeting can generate steady referrals.

Social media/education: Share patient success stories (with permission), explain the connection between mental health and weight, address common concerns. Position yourself as the expert who treats the whole person, not just writes prescriptions.

The key is emphasize your unique value: psychiatric expertise + weight management. That combination is rare and valuable.

GLP-1 Telehealth Compliance: What You Actually Need to Know

The Good News: GLP-1s Aren’t Controlled Substances

This makes telehealth prescribing straightforward. You don’t need an in-person visit. The Ryan Haight Act’s in-person exam requirement applies only to controlled substances. GLP-1 medications are not scheduled drugs.

This means you can legally:

• Establish a patient relationship via video visit
• Prescribe semaglutide, tirzepatide, etc. via telehealth
• Treat patients across state lines (if licensed in their state)

You must:

• Be licensed in the patient’s state of residence
• Conduct a proper medical evaluation (comprehensive history, review of systems, assessment of contraindications)
• Document appropriately
• Follow state-specific telehealth requirements

State-by-State Licensing Reality

Psychiatrists (MD/DO): You need a medical license in the patient’s state. Some states make this easier:

• Interstate Medical Licensure Compact (IMLC): 42 states are members (including Texas, Pennsylvania, Illinois, Florida). This expedites multi-state licensing but still requires separate licenses for each state.
• Florida Telehealth Registration: Out-of-state physicians can register to practice telehealth in Florida without full licensure (can’t prescribe Schedule II, but GLP-1s are fine).
• California and New York: Not in IMLC—you need full state licensure. More paperwork, but not insurmountable.

Psychiatric Nurse Practitioners (PMHNPs): Your scope depends heavily on state rules:

• Full Practice Authority (after experience): New York (3,600 hours), Illinois (4,000 hours + 250 hours education), California (3 years supervised, then independent as of 2026)
• Collaborative Practice Required: Texas, Pennsylvania, Florida (for psych NPs—FL’s independent practice law only applies to primary care NPs)

If you’re a PMHNP in a collaborative state, you’ll need a supervising physician agreement. Many telehealth platforms will pair you with a supervising MD or handle this paperwork.

Standard of Care Essentials

To prescribe GLP-1s safely and compliantly:

Initial Evaluation:

• Comprehensive weight and health history
• BMI calculation (FDA approval: ≥30, or ≥27 with weight-related comorbidity)
• Rule out contraindications (history of medullary thyroid cancer, pancreatitis, pregnancy)
• Baseline labs: A1c, fasting glucose, TSH, liver panel
• Mental health screening (depression, eating disorders, body image issues)
• Informed consent (explain off-label use if using Ozempic for obesity, discuss potential side effects including GI symptoms and rare mood changes)

Ongoing Monitoring:

• At least monthly follow-ups during dose titration (typically first 3-6 months)
• Track weight, side effects, adherence
• Adjust doses according to protocol
• Monitor mental health (mood, anxiety, eating behaviors)
• Provide or refer for nutrition/exercise counseling

Documentation:

• Clear rationale for prescribing (medical necessity, not cosmetic)
• Treatment plan and goals
• Patient education provided
• Follow-up schedule

This isn’t significantly different from managing any chronic medication. If you’re comfortable prescribing psychiatric medications via telehealth, you can do this.

Key State-Specific Nuances

Cash-Pay vs Insurance: The Economic Reality

Here’s the hard truth about insurance coverage for GLP-1 weight loss:

Most insurance doesn’t cover it. As of mid-2024, only 13 state Medicaid programs covered GLP-1s for obesity (California, Pennsylvania, Illinois among them). Many private plans explicitly exclude obesity medications.

Patients who want GLP-1s often pay out-of-pocket:

• Brand-name Wegovy: $1,300+/month without insurance
• Compounded semaglutide: $200-400/month (legal but unregulated—use reputable pharmacies only)

This creates three business model options:

1. Cash-Pay Only

• Pros: Simple operations, no prior auths, direct revenue, patients know upfront costs
• Cons: Limits patient pool to those who can afford $200-400+/month for meds + visit fees
• Typical Model: Monthly subscription ($99-199) includes visits, medication coordination, support; medication billed separately

2. Insurance Billing (for visits)

• Pros: Wider patient access, can bill E/M codes for obesity counseling
• Cons: Prior authorizations, denials, lower reimbursement, patients still often pay cash for meds
• Reality: Even when you bill insurance for visits, patients usually pay cash for medications

3. Hybrid

• Pros: Flexibility—cash for initial comprehensive eval, insurance for follow-ups if covered; attracts both populations
• Cons: More complex billing
• Smart Approach: Charge cash for intensive initial visit ($200-300), then bill insurance for brief follow-ups if patient has coverage; patients always pay for meds separately

What Most Successful Practices Do: Start cash-pay to keep operations simple and test demand. Once you have systems down and steady patient flow, consider adding insurance billing for visits (not meds) to expand access.

Be Transparent: Tell patients upfront what they’ll pay monthly (visits + meds). Patients hate surprise bills. Clear pricing builds trust and reduces no-shows.

Scaling Without Burning Out: The Practical Workflow Guide

This is where most providers fail. They add GLP-1 patients, get overwhelmed, and either burn out or quit offering the service.

Here’s how to scale intelligently:

1. Standardize Your Intake Process

Before you ever see the patient:

• Digital intake forms: Comprehensive medical history, weight history, diet/exercise habits, mental health screening, medications, prior weight-loss attempts
• Automated lab orders: Pre-programmed panel (A1c, TSH, CMP, lipids) sent before first visit
• Educational materials: Send overview of GLP-1s, what to expect, pricing, commitment required

Result: Your first visit is clinical decision-making, not information gathering. Cuts appointment time from 60 minutes to 30-40 minutes.

2. Create Clinical Protocols

Dose Titration Protocol:

• Standard starting dose and escalation schedule (e.g., semaglutide 0.25mg weekly x4 weeks → 0.5mg x4 weeks → 1mg, etc.)
• Clear criteria for when to advance vs hold dose
• Template messages for common side effects (nausea, constipation, fatigue)

Follow-Up Schedule:

• Month 1: Video visit (assess tolerance, titrate dose, reinforce diet/exercise)
• Month 2: Brief video or async check-in (weight, side effects, dose adjustment if needed)
• Month 3: Video visit (progress review, adjust plan)
• Months 4+: Every 2-3 months once stable

Templates for Everything:

• Initial evaluation note
• Follow-up visit note
• Patient education handouts
• Medication teaching (injection technique, storage, what to do if you miss a dose)

Result: Consistent care quality, faster documentation, less cognitive load per patient.

3. Leverage Your Team (Even If It’s Small)

What You Should Delegate:

• Medical Assistant/RN: Collect interim weights, blood pressures, symptom questionnaires; handle routine patient questions via portal; coordinate lab draws
• Health Coach/Dietitian: Nutrition counseling, exercise planning, behavioral support (can be group-based)
• Admin: Scheduling, insurance verification, handling medication pharmacy issues

What Only You Should Do:

• Initial evaluation and diagnosis
• Prescribing and dose adjustments
• Managing complex cases or concerning side effects
• Mental health assessment and treatment

Reality Check: If you’re solo, you can still scale—but you’ll need to be more selective about patient volume and use technology heavily (see below). Consider hiring a part-time RN or contracting with a health coach as you grow.

4. Use Technology to Multiply Your Impact

Essential Tools:

• Telehealth platform with integrated video, e-prescribing, messaging: Reduces friction, keeps everything in one place
• Automated appointment reminders: Cuts no-shows significantly
• Patient portal for async check-ins: Patients submit weekly weights, photos, questions between visits; you review in batches
• Template library: Pre-written responses to common questions, automated educational content triggered by prescription
• Connected scale or app-based tracking: Patients log weights in app, you see trends at a glance

Optional But Powerful:

• AI-powered chatbot: Handles FAQs (‘Is nausea normal?’, ‘Can I take this with food?’), triages messages
• Group video sessions: Monthly 30-minute group Q&A or educational session for all GLP-1 patients (builds community, reduces individual counseling load)

Result: You can manage 50-100+ active GLP-1 patients without drowning in messages or documentation.

5. Batch Your Work

Don’t scatter GLP-1 patients throughout your week. Batch them:

• Block scheduling: Dedicate specific half-days to GLP-1 visits (e.g., Tuesday afternoons, Thursday mornings)
• Group async reviews: Set aside 30 minutes daily to review all portal messages, weight updates, lab results at once
• Same protocols, faster flow: When you’re in ‘GLP-1 mode,’ you’re not context-switching between psychiatric medication management and weight loss

Result: More efficient, less mental strain, easier to maintain focus.

6. Set Clear Boundaries

Patient Expectations:

• Response time for non-urgent messages: 24-48 business hours
• After-hours availability: Emergency psychiatric issues only (not GLP-1 questions)
• Follow-up frequency: Set schedule, no ad-hoc ‘I need to check in’ visits

Your Capacity Limits:

• Start small: 10-20 GLP-1 patients, see how it feels
• Scale gradually: Add 5-10 patients/month until you hit your comfortable limit
• Know your max: Maybe it’s 50 patients, maybe it’s 200—depends on your support structure and other practice demands

Preserve Your Core Practice:

• If you love psychiatric work, keep doing it—GLP-1 can be 20-30% of your practice, not 100%
• If you want to transition fully to weight management, phase it over 6-12 months

Result: Sustainable growth that doesn’t destroy your work-life balance.

7. Monitor Your Own Well-Being

Warning signs you’re scaling too fast:

• Dreading GLP-1 appointments
• Cutting corners on documentation or patient education
• Missing meals, sleep, or exercise to keep up
• Feeling resentful toward patients

If you see these signs:

• Pause new patient intake temporarily
• Hire help (even part-time support makes a huge difference)
• Raise your prices (fewer patients, same or better revenue, less volume stress)
• Improve systems (often the problem is inefficiency, not capacity)

Protect your energy:

• Schedule regular time off (block it in your calendar, treat it as sacred)
• Keep some variety in your practice (mix of patient types, case complexity)
• Join a community of practice (obesity medicine interest group, telehealth clinician forum) for support and idea-sharing

The Bottom Line on Scaling

You can build a thriving GLP-1 practice that generates significant revenue and helps hundreds of patients—without burning out—if you:

1. Use platforms (like Klarity) that handle patient acquisition, so you’re not gambling on expensive marketing
2. Standardize your clinical workflows with protocols and templates
3. Leverage technology and delegation to multiply your impact
4. Set clear boundaries and monitor your capacity
5. Scale gradually based on what feels sustainable

This isn’t about becoming a prescription factory. It’s about building a system that lets you deliver excellent care efficiently, to more people, while maintaining your own health and sanity.

Why This Opportunity Won’t Last Forever

Right now, there’s a massive supply-demand mismatch. Millions of patients want GLP-1s. A relatively small number of providers (especially those offering holistic, mental-health-informed care) are offering them.

But that window is closing:

• More primary care providers are adding GLP-1 prescribing
• Telehealth companies are recruiting aggressively
• Nurse practitioners in independent practice states are entering the market
• As competition increases, patient acquisition gets harder and more expensive

The providers who build GLP-1 practices now—with smart systems, strong patient relationships, and efficient operations—will have:

• Established patient bases (retention is easier than acquisition)
• Refined workflows (competitive advantage)
• Brand recognition in their markets
• Economic moats (hard to compete with someone who’s already efficient and trusted)

The providers who wait will face:

• More competition for the same patients
• Higher marketing costs
• Lower margins
• Harder time differentiating

This isn’t about rushing or cutting corners. It’s about recognizing that first-movers who execute well build durable advantages.

Your Next Step

If you’re ready to explore adding GLP-1 weight management to your practice—without the risk of spending thousands on marketing that might not work—joining a platform like Klarity Health is the lowest-risk, highest-return path.

You get:

• Immediate patient flow: Pre-qualified patients matched to your availability and expertise
• Predictable economics: Pay only when you see patients, no upfront marketing spend
• Built-in infrastructure: Telehealth platform, scheduling, patient communication
• Support and training: Clinical protocols, compliance guidance, community of providers

Versus the DIY path:

• $3,000-5,000/month on ads and SEO with uncertain results
• 6-12 months before you see meaningful patient flow from SEO
• Building everything from scratch (platform, systems, marketing, compliance)

For most providers, especially those starting out or looking to scale efficiently, the platform approach removes all the risk and lets you focus on what you do best: taking care of patients.

Learn more about joining Klarity’s provider network and start building your GLP-1 practice today—without the burnout.

Frequently Asked Questions

Can I prescribe GLP-1s via telehealth legally?

Yes. GLP-1 medications are not controlled substances, so the Ryan Haight Act’s in-person requirement doesn’t apply. You must be licensed in the patient’s state and conduct a proper evaluation via video, but no in-person visit is required. State telehealth laws vary slightly, but no state prohibits GLP-1 prescribing via telemedicine if you meet standard-of-care requirements.

Do I need special training or certification to prescribe GLP-1s?

No special certification is required—if you can legally prescribe medications in your state, you can prescribe GLP-1s. However, familiarizing yourself with obesity medicine basics, GLP-1 dosing protocols, and common side effects is essential. Many providers pursue CME in obesity medicine or join professional groups for ongoing education and support.

What if I’m a PMHNP in a state that requires physician collaboration?

You’ll need a collaborative practice agreement with a physician. Many telehealth platforms (including Klarity) can help facilitate these arrangements, pairing you with a supervising physician or providing template agreements. The physician doesn’t need to be on-site but must be available for consultation and periodic chart review per state requirements.

How much can I realistically earn from a GLP-1 practice?

This depends on your model and volume. Cash-pay practices often charge $100-200 per initial visit and $50-100 per follow-up, plus some earn margins on medication sales or charge monthly subscription fees ($99-199). A provider seeing 50 active GLP-1 patients (with 15-20 visits/month between new and follow-ups) could generate $2,000-4,000+/month in direct revenue. Insurance-based models have lower per-visit revenue but potentially higher volume. The key is balancing volume with efficiency—higher patient numbers only work if you have systems to support them.

Should I offer cash-pay or take insurance for GLP-1 services?

Most successful telehealth GLP-1 practices start with cash-pay because insurance coverage for obesity medications is limited and prior authorizations are time-consuming. Cash-pay simplifies operations and gives you direct revenue. You can always add insurance billing later for visits (though patients will likely still pay cash for medications). A hybrid approach—cash for comprehensive initial evaluations, insurance for follow-ups if the patient has coverage—gives you flexibility.

What’s the time commitment per patient?

Initial evaluations typically take 30-45 minutes (if you use pre-visit intake forms and protocols). Follow-up visits are usually 15-20 minutes monthly during dose titration, then every 2-3 months once stable. With efficient systems (templates, async check-ins, team support), you can manage 50+ patients without overwhelming your schedule. The key is not letting GLP-1 patients consume your entire week—batch scheduling and delegation are essential.

What are the biggest compliance risks?

The main risks are: (1) prescribing without adequate evaluation (skipping medical history, contraindications screening, labs), (2) poor documentation (if you can’t prove medical necessity, you’re exposed), (3) using sketchy compounding pharmacies (FDA has warned about unregulated semaglutide sources), and (4) practicing across state lines without proper licensure. Mitigate these by following standard-of-care protocols, documenting thoroughly, partnering only with reputable pharmacies, and ensuring you’re licensed in every state where your patients are located.

How do I handle patients who just want the medication without doing the work?

Set expectations upfront: GLP-1s are tools, not magic. During the initial visit, discuss the importance of nutrition, exercise, and behavioral change. If a patient isn’t willing to engage (skips follow-ups, doesn’t track progress, ignores lifestyle recommendations), you can choose not to continue prescribing. Having clear program requirements (e.g., monthly check-ins mandatory, must submit weekly weights) helps filter for motivated patients and protects you from liability if outcomes are poor.

What if a patient develops concerning mental health symptoms on a GLP-1?

This is where your psychiatric expertise is invaluable. While FDA found no clear causal link between GLP-1s and suicide, mood changes can occur. If a patient reports new or worsening depression, anxiety, or suicidal thoughts: (1) assess severity and safety immediately, (2) consider holding or reducing the GLP-1 dose, (3) address the psychiatric symptoms directly (medication, therapy referral, safety planning), and (4) document everything. You can collaborate with their existing mental health providers if they have them, or manage both issues yourself. Having this dual expertise is a major differentiator.

Can I combine GLP-1 treatment with my existing psychiatric practice?

Absolutely. Many psychiatrists find that offering weight management enhances their psychiatric practice—patients appreciate the holistic approach, and addressing weight gain from psychiatric medications improves adherence and outcomes. You can offer GLP-1s only to existing patients, or market it more broadly to attract new patients. Some providers dedicate specific time blocks to GLP-1 visits to avoid disrupting psychiatric appointment flow. The key is integration that feels natural, not forced.

References and Sources

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage trends), May 27, 2025. Available at: www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ (expert analysis on obesity prevalence and GLP-1 adoption), October 20, 2025. Available at: www.confectionerynews.com

3. PharmaNewsIntelligence via Schizophrenia Forum – Survey finding that nearly half of psychiatrists prescribe or recommend Ozempic and similar weight-loss drugs, November 6, 2023. Available at: forum.schizophrenia.com

4. Medical Director Co. – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide’ (overview of GLP-1 prescribing regulations, NP collaboration requirements, and telehealth standards), 2025. Available at: www.medicaldirectorco.com

5. SingleAim Health – ‘Nurse Practitioner Collaborative Agreement Templates: 50-State Guide’ (state-by-state NP scope of practice and supervision requirements including PA and IL), 2023. Available at: www.singleaimhealth.com

6. California Board of Registered Nursing – AB 890 Implementation FAQ (details on 103 NP and 104 NP independent practice pathways), updated November 2024. Available at: www.rn.ca.gov

7. Wheel Health – ‘Florida Telehealth Regulations and Laws’ (out-of-state telehealth provider registration, prescription restrictions, and standard of care requirements), 2022. Available at: www.wheel.com

8. Commonwealth of Pennsylvania Press Release – ‘Shapiro Administration expands job opportunities for doctors, nurses…’ (announcement of PA joining Interstate Nurse Licensure Compact), June 23, 2025. Available at: www.pa.gov

9. Rivkin Radler LLP – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (details on NY’s 3,600-hour requirement for NP full practice authority), April 2022. Available at: www.rivkinrounds.com

10. Axios – ‘America’s doctors need more obesity medicine training’ (analysis of provider shortage, training gaps, and patient monitoring requirements for GLP-1 therapy), May 28, 2024. Available at: www.axios.com

11. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ (examination of insurance coverage limitations, patient out-of-pocket costs, and cash-pay market dynamics), August 22, 2025. Available at: time.com

12. Axios – ‘States slow to cover GLP-1s for weight loss’ (KFF analysis showing only 13 state Medicaid programs covering obesity medications as of mid-2024), November 5, 2024. Available at: www.axios.com

13. Metabolic Mind Podcast – ‘Psychiatrist Shares His Experience with GLP-1 Weight Loss Drugs with Dr. Rodrigo Mansuer’ (discussion of psychiatric side effects, suicidal ideation concerns, and FDA guidance), 2023-2024. Available at: www.metabolicmind.org

14. CompHealth – ‘Interstate Medical Licensure Compact Guide’ (list of IMLC member states and expedited licensing process for physicians), updated 2024. Available at: comphealth.com

15. Florida Senate – Florida Statutes 464.0123 (Autonomous APRN practice statute defining primary care scope restriction), 2023. Available at: [www.flsen

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is